APO Research
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceuticals for Diagnosis

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Radiopharmaceuticals for Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025190 pages

Choose your research edition.

Industry ResearchRadiopharmaceuticals for Diagnosis Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceuticals for Diagnosis Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Radiopharmaceuticals for Diagnosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceuticals for Diagnosis Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceuticals for Diagnosis Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Radiopharmaceuticals for Diagnosis market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Radiopharmaceuticals for Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Radiopharmaceuticals for Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Radiopharmaceuticals for Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Radiopharmaceuticals for Diagnosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Radiopharmaceuticals for Diagnosis include Atom High-tech Co., Ltd., Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory, Tianjin Said Biopharmaceutical Co., Ltd., Shenzhen Larven Bioengineering Technology Co., Ltd., Shanghai Atom Kexing Pharmaceutical Co., Ltd., Shanghai Xinke Pharmaceutical Co., Ltd., Ningbo Jun'an Pharmaceutical Technology Co., Ltd., Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. and Guangdong Xi'ai Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Radiopharmaceuticals for Diagnosis market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Radiopharmaceuticals for Diagnosis and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radiopharmaceuticals for Diagnosis sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radiopharmaceuticals for Diagnosis market size, projected growth trends, production technologies, key applications, and end-use industries.

Radiopharmaceuticals for Diagnosis Segment by Company

Atom High-tech Co., Ltd.

Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory

Tianjin Said Biopharmaceutical Co., Ltd.

Shenzhen Larven Bioengineering Technology Co., Ltd.

Shanghai Atom Kexing Pharmaceutical Co., Ltd.

Shanghai Xinke Pharmaceutical Co., Ltd.

Ningbo Jun'an Pharmaceutical Technology Co., Ltd.

Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.

Guangdong Xi'ai Pharmaceutical Co., Ltd.

Chengdu Zhonghe Gaotong Isotope Co., Ltd.

Chengdu Yunke Pharmaceutical Co., Ltd.

Chengdu Xinke Pharmaceutical Co., Ltd.

Beijing Zhibo High-tech Biotechnology Co., Ltd.

RadioMedix, Inc.

PDRadiopharma Inc.

Lantheus

Jubilant Radiopharma

GE Healthcare Ltd

DOE IP

Radiopharmaceuticals for Diagnosis Segment by Type

Strontium [89Sr] Chloride

Sodium Iodide [131I]

Iodine [125I] Sealed Seed Source

Technetium [99mTc] Pentetate

Technetium [99mTc] Polymerized Albumin

Technetium [99mTc] Dithiodithiocarbamate

Other

Radiopharmaceuticals for Diagnosis Segment by Application

Hospital

Clinic

Other

Radiopharmaceuticals for Diagnosis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals for Diagnosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals for Diagnosis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals for Diagnosis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Radiopharmaceuticals for Diagnosis market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Radiopharmaceuticals for Diagnosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Radiopharmaceuticals for Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Radiopharmaceuticals for Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Radiopharmaceuticals for Diagnosis Industry Trends Table 2. Radiopharmaceuticals for Diagnosis Industry Drivers Table 3. Radiopharmaceuticals for Diagnosis Industry Opportunities and Challenges Table 4. Radiopharmaceuticals for Diagnosis Industry Restraints Table 5. Global Radiopharmaceuticals for Diagnosis Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Radiopharmaceuticals for Diagnosis Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Manufacturers Table 9. Global Radiopharmaceuticals for Diagnosis Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Radiopharmaceuticals for Diagnosis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Radiopharmaceuticals for Diagnosis Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Radiopharmaceuticals for Diagnosis Manufacturers, Product Type & Application Table 13. Global Radiopharmaceuticals for Diagnosis Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Radiopharmaceuticals for Diagnosis by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Strontium [89Sr] Chloride Table 17. Major Manufacturers of Sodium Iodide [131I] Table 18. Major Manufacturers of Iodine [125I] Sealed Seed Source Table 19. Major Manufacturers of Technetium [99mTc] Pentetate Table 20. Major Manufacturers of Technetium [99mTc] Polymerized Albumin Table 21. Major Manufacturers of Technetium [99mTc] Dithiodithiocarbamate Table 22. Major Manufacturers of Other Table 23. Global Radiopharmaceuticals for Diagnosis Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Radiopharmaceuticals for Diagnosis Sales by Type (2021-2026) & (K Units) Table 25. Global Radiopharmaceuticals for Diagnosis Sales by Type (2027-2032) & (K Units) Table 26. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2026) Table 27. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2027-2032) Table 28. Global Radiopharmaceuticals for Diagnosis Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 29. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2026) & (K Units) Table 30. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2027-2032) & (K Units) Table 31. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2021-2026) Table 32. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Hospital Table 34. Major Manufacturers of Clinic Table 35. Major Manufacturers of Other Table 36. Global Radiopharmaceuticals for Diagnosis Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Radiopharmaceuticals for Diagnosis Sales by Application (2021-2026) & (K Units) Table 38. Global Radiopharmaceuticals for Diagnosis Sales by Application (2027-2032) & (K Units) Table 39. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2026) Table 40. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2027-2032) Table 41. Global Radiopharmaceuticals for Diagnosis Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2026) & (K Units) Table 43. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2027-2032) & (K Units) Table 44. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2021-2026) Table 45. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2027-2032) Table 46. Global Radiopharmaceuticals for Diagnosis Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Radiopharmaceuticals for Diagnosis Sales by Region (2021-2026) & (K Units) Table 48. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Region (2021-2026) Table 49. Global Radiopharmaceuticals for Diagnosis Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Radiopharmaceuticals for Diagnosis Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Radiopharmaceuticals for Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 53. North America Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 54. Europe Radiopharmaceuticals for Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 56. Europe Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Radiopharmaceuticals for Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country (2027-2032) & (K Units) Table 63. Global Radiopharmaceuticals for Diagnosis Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Radiopharmaceuticals for Diagnosis Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Radiopharmaceuticals for Diagnosis Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2021-2026) Table 67. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2027-2032) Table 68. Atom High-tech Co., Ltd. Company Information Table 69. Atom High-tech Co., Ltd. Business Overview Table 70. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 72. Atom High-tech Co., Ltd. Recent Development Table 73. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information Table 74. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview Table 75. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolio Table 77. Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Development Table 78. Tianjin Said Biopharmaceutical Co., Ltd. Company Information Table 79. Tianjin Said Biopharmaceutical Co., Ltd. Business Overview Table 80. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 82. Tianjin Said Biopharmaceutical Co., Ltd. Recent Development Table 83. Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information Table 84. Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview Table 85. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 87. Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Development Table 88. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information Table 89. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview Table 90. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 92. Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Development Table 93. Shanghai Xinke Pharmaceutical Co., Ltd. Company Information Table 94. Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview Table 95. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 97. Shanghai Xinke Pharmaceutical Co., Ltd. Recent Development Table 98. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information Table 99. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview Table 100. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 102. Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Development Table 103. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information Table 104. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview Table 105. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 107. Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Development Table 108. Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information Table 109. Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview Table 110. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 112. Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Development Table 113. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information Table 114. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview Table 115. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 117. Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Development Table 118. Chengdu Yunke Pharmaceutical Co., Ltd. Company Information Table 119. Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview Table 120. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 122. Chengdu Yunke Pharmaceutical Co., Ltd. Recent Development Table 123. Chengdu Xinke Pharmaceutical Co., Ltd. Company Information Table 124. Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview Table 125. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 127. Chengdu Xinke Pharmaceutical Co., Ltd. Recent Development Table 128. Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information Table 129. Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview Table 130. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio Table 132. Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Development Table 133. RadioMedix, Inc. Company Information Table 134. RadioMedix, Inc. Business Overview Table 135. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolio Table 137. RadioMedix, Inc. Recent Development Table 138. PDRadiopharma Inc. Company Information Table 139. PDRadiopharma Inc. Business Overview Table 140. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolio Table 142. PDRadiopharma Inc. Recent Development Table 143. Lantheus Company Information Table 144. Lantheus Business Overview Table 145. Lantheus Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Lantheus Radiopharmaceuticals for Diagnosis Product Portfolio Table 147. Lantheus Recent Development Table 148. Jubilant Radiopharma Company Information Table 149. Jubilant Radiopharma Business Overview Table 150. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolio Table 152. Jubilant Radiopharma Recent Development Table 153. GE Healthcare Ltd Company Information Table 154. GE Healthcare Ltd Business Overview Table 155. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolio Table 157. GE Healthcare Ltd Recent Development Table 158. DOE IP Company Information Table 159. DOE IP Business Overview Table 160. DOE IP Radiopharmaceuticals for Diagnosis Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. DOE IP Radiopharmaceuticals for Diagnosis Product Portfolio Table 162. DOE IP Recent Development Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Radiopharmaceuticals for Diagnosis Distributors List Table 166. Radiopharmaceuticals for Diagnosis Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Radiopharmaceuticals for Diagnosis Product Image Figure 2. Global Radiopharmaceuticals for Diagnosis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceuticals for Diagnosis Market Size (2021-2032) & (US$ Million) Figure 4. Global Radiopharmaceuticals for Diagnosis Sales (2021-2032) & (K Units) Figure 5. Global Radiopharmaceuticals for Diagnosis Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Radiopharmaceuticals for Diagnosis Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Strontium [89Sr] Chloride Image Figure 9. Sodium Iodide [131I] Image Figure 10. Iodine [125I] Sealed Seed Source Image Figure 11. Technetium [99mTc] Pentetate Image Figure 12. Technetium [99mTc] Polymerized Albumin Image Figure 13. Technetium [99mTc] Dithiodithiocarbamate Image Figure 14. Other Image Figure 15. Global Radiopharmaceuticals for Diagnosis Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Radiopharmaceuticals for Diagnosis Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2032) Figure 18. Global Radiopharmaceuticals for Diagnosis Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Radiopharmaceuticals for Diagnosis Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2021-2032) Figure 21. Hospital Image Figure 22. Clinic Image Figure 23. Other Image Figure 24. Global Radiopharmaceuticals for Diagnosis Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Radiopharmaceuticals for Diagnosis Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2032) Figure 27. Global Radiopharmaceuticals for Diagnosis Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Radiopharmaceuticals for Diagnosis Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2021-2032) Figure 30. North America Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2032) Figure 32. U.S. Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2032) Figure 37. Germany Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2032) Figure 44. China Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Market Share by Country (2021-2032) Figure 52. Brazil Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Radiopharmaceuticals for Diagnosis Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Radiopharmaceuticals for Diagnosis Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Figure 63. North America Radiopharmaceuticals for Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Figure 65. Europe Radiopharmaceuticals for Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Radiopharmaceuticals for Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Radiopharmaceuticals for Diagnosis Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Radiopharmaceuticals for Diagnosis Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Strontium [89Sr] Chloride
  • Sodium Iodide [131I]
  • Iodine [125I] Sealed Seed Source
  • Technetium [99mTc] Pentetate
  • Technetium [99mTc] Polymerized Albumin
  • Technetium [99mTc] Dithiodithiocarbamate
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Atom High-tech Co., Ltd.
  • Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
  • Tianjin Said Biopharmaceutical Co., Ltd.
  • Shenzhen Larven Bioengineering Technology Co., Ltd.
  • Shanghai Atom Kexing Pharmaceutical Co., Ltd.
  • Shanghai Xinke Pharmaceutical Co., Ltd.
  • Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
  • Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
  • Guangdong Xi'ai Pharmaceutical Co., Ltd.
  • Chengdu Zhonghe Gaotong Isotope Co., Ltd.
  • Chengdu Yunke Pharmaceutical Co., Ltd.
  • Chengdu Xinke Pharmaceutical Co., Ltd.
  • Beijing Zhibo High-tech Biotechnology Co., Ltd.
  • RadioMedix, Inc.
  • PDRadiopharma Inc.
  • Lantheus
  • Jubilant Radiopharma
  • GE Healthcare Ltd
  • DOE IP

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Radiopharmaceuticals for Diagnosis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Radiopharmaceuticals for Diagnosis Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Radiopharmaceuticals for Diagnosis Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Radiopharmaceuticals for Diagnosis Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Radiopharmaceuticals for Diagnosis Market Dynamics
  1. 2.1 Radiopharmaceuticals for Diagnosis Industry Trends
  2. 2.2 Radiopharmaceuticals for Diagnosis Industry Drivers
  3. 2.3 Radiopharmaceuticals for Diagnosis Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceuticals for Diagnosis Industry Restraints
3 Radiopharmaceuticals for Diagnosis Market by Manufacturers
  1. 3.1 Global Radiopharmaceuticals for Diagnosis Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Radiopharmaceuticals for Diagnosis Sales by Manufacturers (2021-2026)
  3. 3.3 Global Radiopharmaceuticals for Diagnosis Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Radiopharmaceuticals for Diagnosis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Radiopharmaceuticals for Diagnosis Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Radiopharmaceuticals for Diagnosis Manufacturers, Product Type & Application
  7. 3.7 Global Radiopharmaceuticals for Diagnosis Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Radiopharmaceuticals for Diagnosis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Radiopharmaceuticals for Diagnosis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Radiopharmaceuticals for Diagnosis Tier 1, Tier 2, and Tier 3
4 Radiopharmaceuticals for Diagnosis Market by Type
  1. 4.1 Radiopharmaceuticals for Diagnosis Type Introduction
  2. 4.1.1 Strontium [89Sr] Chloride
  3. 4.1.2 Sodium Iodide [131I]
  4. 4.1.3 Iodine [125I] Sealed Seed Source
  5. 4.1.4 Technetium [99mTc] Pentetate
  6. 4.1.5 Technetium [99mTc] Polymerized Albumin
  7. 4.1.6 Technetium [99mTc] Dithiodithiocarbamate
  8. 4.1.7 Other
  9. 4.2 Global Radiopharmaceuticals for Diagnosis Sales by Type
  10. 4.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Radiopharmaceuticals for Diagnosis Sales by Type (2021-2032)
  12. 4.2.3 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Type (2021-2032)
  13. 4.3 Global Radiopharmaceuticals for Diagnosis Revenue by Type
  14. 4.3.1 Global Radiopharmaceuticals for Diagnosis Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Radiopharmaceuticals for Diagnosis Revenue by Type (2021-2032)
  16. 4.3.3 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Type (2021-2032)
5 Radiopharmaceuticals for Diagnosis Market by Application
  1. 5.1 Radiopharmaceuticals for Diagnosis Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Radiopharmaceuticals for Diagnosis Sales by Application
  6. 5.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Radiopharmaceuticals for Diagnosis Sales by Application (2021-2032)
  8. 5.2.3 Global Radiopharmaceuticals for Diagnosis Sales Market Share by Application (2021-2032)
  9. 5.3 Global Radiopharmaceuticals for Diagnosis Revenue by Application
  10. 5.3.1 Global Radiopharmaceuticals for Diagnosis Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Radiopharmaceuticals for Diagnosis Revenue by Application (2021-2032)
  12. 5.3.3 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Application (2021-2032)
6 Global Radiopharmaceuticals for Diagnosis Sales by Region
  1. 6.1 Global Radiopharmaceuticals for Diagnosis Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radiopharmaceuticals for Diagnosis Sales by Region (2021-2032)
  3. 6.2.1 Global Radiopharmaceuticals for Diagnosis Sales by Region (2021-2026)
  4. 6.2.2 Global Radiopharmaceuticals for Diagnosis Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Radiopharmaceuticals for Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Radiopharmaceuticals for Diagnosis Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Radiopharmaceuticals for Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Radiopharmaceuticals for Diagnosis Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Radiopharmaceuticals for Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Radiopharmaceuticals for Diagnosis Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Radiopharmaceuticals for Diagnosis Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Radiopharmaceuticals for Diagnosis Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Radiopharmaceuticals for Diagnosis Revenue by Region
  1. 7.1 Global Radiopharmaceuticals for Diagnosis Revenue by Region
  2. 7.1.1 Global Radiopharmaceuticals for Diagnosis Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Radiopharmaceuticals for Diagnosis Revenue by Region (2021-2026)
  4. 7.1.3 Global Radiopharmaceuticals for Diagnosis Revenue by Region (2027-2032)
  5. 7.1.4 Global Radiopharmaceuticals for Diagnosis Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Radiopharmaceuticals for Diagnosis Revenue (2021-2032)
  8. 7.2.2 North America Radiopharmaceuticals for Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Radiopharmaceuticals for Diagnosis Revenue (2021-2032)
  11. 7.3.2 Europe Radiopharmaceuticals for Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Radiopharmaceuticals for Diagnosis Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Radiopharmaceuticals for Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Radiopharmaceuticals for Diagnosis Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Atom High-tech Co., Ltd.
  2. 8.1.1 Atom High-tech Co., Ltd. Company Information
  3. 8.1.2 Atom High-tech Co., Ltd. Business Overview
  4. 8.1.3 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Atom High-tech Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  6. 8.1.5 Atom High-tech Co., Ltd. Recent Developments
  7. 8.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory
  8. 8.2.1 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Company Information
  9. 8.2.2 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Business Overview
  10. 8.2.3 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Radiopharmaceuticals for Diagnosis Product Portfolio
  12. 8.2.5 Wuxi Jiangyuan Industrial Technology and Trade Co., Ltd. Jiangyuan Pharmaceutical Factory Recent Developments
  13. 8.3 Tianjin Said Biopharmaceutical Co., Ltd.
  14. 8.3.1 Tianjin Said Biopharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Tianjin Said Biopharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Tianjin Said Biopharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  18. 8.3.5 Tianjin Said Biopharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Shenzhen Larven Bioengineering Technology Co., Ltd.
  20. 8.4.1 Shenzhen Larven Bioengineering Technology Co., Ltd. Company Information
  21. 8.4.2 Shenzhen Larven Bioengineering Technology Co., Ltd. Business Overview
  22. 8.4.3 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shenzhen Larven Bioengineering Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  24. 8.4.5 Shenzhen Larven Bioengineering Technology Co., Ltd. Recent Developments
  25. 8.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd.
  26. 8.5.1 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  30. 8.5.5 Shanghai Atom Kexing Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Shanghai Xinke Pharmaceutical Co., Ltd.
  32. 8.6.1 Shanghai Xinke Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Shanghai Xinke Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  36. 8.6.5 Shanghai Xinke Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Ningbo Jun'an Pharmaceutical Technology Co., Ltd.
  38. 8.7.1 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Company Information
  39. 8.7.2 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Business Overview
  40. 8.7.3 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  42. 8.7.5 Ningbo Jun'an Pharmaceutical Technology Co., Ltd. Recent Developments
  43. 8.8 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd.
  44. 8.8.1 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  48. 8.8.5 Guangzhou Atom High-tech Isotope Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Guangdong Xi'ai Pharmaceutical Co., Ltd.
  50. 8.9.1 Guangdong Xi'ai Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Guangdong Xi'ai Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Guangdong Xi'ai Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  54. 8.9.5 Guangdong Xi'ai Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Chengdu Zhonghe Gaotong Isotope Co., Ltd.
  56. 8.10.1 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Company Information
  57. 8.10.2 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Business Overview
  58. 8.10.3 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  60. 8.10.5 Chengdu Zhonghe Gaotong Isotope Co., Ltd. Recent Developments
  61. 8.11 Chengdu Yunke Pharmaceutical Co., Ltd.
  62. 8.11.1 Chengdu Yunke Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Chengdu Yunke Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Chengdu Yunke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  66. 8.11.5 Chengdu Yunke Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Chengdu Xinke Pharmaceutical Co., Ltd.
  68. 8.12.1 Chengdu Xinke Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Chengdu Xinke Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Chengdu Xinke Pharmaceutical Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  72. 8.12.5 Chengdu Xinke Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Beijing Zhibo High-tech Biotechnology Co., Ltd.
  74. 8.13.1 Beijing Zhibo High-tech Biotechnology Co., Ltd. Company Information
  75. 8.13.2 Beijing Zhibo High-tech Biotechnology Co., Ltd. Business Overview
  76. 8.13.3 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Beijing Zhibo High-tech Biotechnology Co., Ltd. Radiopharmaceuticals for Diagnosis Product Portfolio
  78. 8.13.5 Beijing Zhibo High-tech Biotechnology Co., Ltd. Recent Developments
  79. 8.14 RadioMedix, Inc.
  80. 8.14.1 RadioMedix, Inc. Company Information
  81. 8.14.2 RadioMedix, Inc. Business Overview
  82. 8.14.3 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 RadioMedix, Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
  84. 8.14.5 RadioMedix, Inc. Recent Developments
  85. 8.15 PDRadiopharma Inc.
  86. 8.15.1 PDRadiopharma Inc. Company Information
  87. 8.15.2 PDRadiopharma Inc. Business Overview
  88. 8.15.3 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 PDRadiopharma Inc. Radiopharmaceuticals for Diagnosis Product Portfolio
  90. 8.15.5 PDRadiopharma Inc. Recent Developments
  91. 8.16 Lantheus
  92. 8.16.1 Lantheus Company Information
  93. 8.16.2 Lantheus Business Overview
  94. 8.16.3 Lantheus Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Lantheus Radiopharmaceuticals for Diagnosis Product Portfolio
  96. 8.16.5 Lantheus Recent Developments
  97. 8.17 Jubilant Radiopharma
  98. 8.17.1 Jubilant Radiopharma Company Information
  99. 8.17.2 Jubilant Radiopharma Business Overview
  100. 8.17.3 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Jubilant Radiopharma Radiopharmaceuticals for Diagnosis Product Portfolio
  102. 8.17.5 Jubilant Radiopharma Recent Developments
  103. 8.18 GE Healthcare Ltd
  104. 8.18.1 GE Healthcare Ltd Company Information
  105. 8.18.2 GE Healthcare Ltd Business Overview
  106. 8.18.3 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 GE Healthcare Ltd Radiopharmaceuticals for Diagnosis Product Portfolio
  108. 8.18.5 GE Healthcare Ltd Recent Developments
  109. 8.19 DOE IP
  110. 8.19.1 DOE IP Company Information
  111. 8.19.2 DOE IP Business Overview
  112. 8.19.3 DOE IP Radiopharmaceuticals for Diagnosis Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 DOE IP Radiopharmaceuticals for Diagnosis Product Portfolio
  114. 8.19.5 DOE IP Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Radiopharmaceuticals for Diagnosis Value Chain Analysis
  2. 9.1.1 Radiopharmaceuticals for Diagnosis Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Radiopharmaceuticals for Diagnosis Production Mode & Process
  6. 9.2 Radiopharmaceuticals for Diagnosis Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Radiopharmaceuticals for Diagnosis Distributors
  9. 9.2.3 Radiopharmaceuticals for Diagnosis Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst